Skip to Main Content

Author Details

Han Liang
MD Anderson Cancer Center
2005
146
64
PMIDPaper TitleJournal TitlePublished Year
32341528Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.Nat Genet2023
37822029Data-adaptive and pathway-based tests for association studies between somatic mutations and germline variations in human cancers.Genet Epidemiol2023
37260986Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma.Front Oncol2023
36734079Cancer Cells Employ the Most Prolific RNA Editors: A Closer Look at the Single-Cell Level.Cancer Res2023
36166093Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.Clin Cancer Res2023
32047324Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.Nat Genet2023
34492340Convergent Usage of Amino Acids in Human Cancers as A Reversed Process of Tissue Development.Genomics Proteomics Bioinformatics2022
35353808RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells.PLoS Genet2022
36309506Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets.Nat Commun2022
36131018A cellular hierarchy in melanoma uncouples growth and metastasis.Nature2022
35138907A functional genomic approach to actionable gene fusions for precision oncology.Sci Adv2022
32976776Next-Generation Analytics for Omics Data.Cancer Cell2021
33740422More reliable breast cancer risk assessment for every woman.Cancer Cell2021
33753855A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma.Commun Biol2021
34921145A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis.Nat Commun2021
34425866Systematic functional interrogation of human pseudogenes using CRISPRi.Genome Biol2021
34344966Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.Sci Rep2021
34117242Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.Nat Commun2021
34362903Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer.Nat Commun2021
31586392APAatlas: decoding alternative polyadenylation across human tissues.Nucleic Acids Res2020
35121839Finding cancer drivers in the UPS system.Nat Cancer2020
32024997Comprehensive molecular characterization of mitochondrial genomes in human cancers.Nat Genet2020
32079540Comprehensive assessment of computational algorithms in predicting cancer driver mutations.Genome Biol2020
33157050Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.Cancer Cell2020
33007258A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.Cancer Cell2020
32330068Predicting Cancer Cell Line Dependencies From the Protein Expression Data of Reverse-Phase Protein Arrays.JCO Clin Cancer Inform2020
32270762Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression.Elife2020
32265228Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.Cancer Immunol Res2020
32133402Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy.Sci Adv2020
32374631Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome.JCO Clin Cancer Inform2020
29579225Distinct telomere length and molecular signatures in seminoma and non-seminoma of testicular germ cell tumor.Brief Bioinform2019
31984309Characterization of Hypoxia-associated Molecular Features to Aid Hypoxia-Targeted Therapy.Nat Metab2019
31772231Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network.Nat Commun2019
31682236A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.J Clin Invest2019
31820393Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance.Adv Exp Med Biol2019
31820386Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.Adv Exp Med Biol2019
31201206TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.Mol Cell Proteomics2019
31541696Sex disparities in cancer.Cancer Lett2019
30423406SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.Cancer Lett2019
30545954Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health.Pharmacol Rev2019
28607096The somatic mutation landscape of premalignant colorectal adenoma.Gut2018
29891922SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.Nat Commun2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
30254248RNA editing derived epitopes function as cancer antigens to elicit immune responses.Nat Commun2018
30297783Personalized Integrated Network Modeling of the Cancer Proteome Atlas.Sci Rep2018
30297703Biosynthetic energy cost for amino acids decreases in cancer evolution.Nat Commun2018
30349115Long noncoding RNA MALAT1 suppresses breast cancer metastasis.Nat Genet2018
30446657NUAK2 is a critical YAP target in liver cancer.Nat Commun2018
30380420Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.Cell Rep2018
29617665Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.Cell Rep2018
  • 1 - 50 of 146

Recommended Authors

Hui Yu
Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 2017
Number of shared co-authors 2
Travers Ching
Adaptive Biotechnologies
Career Start Year 2014
Number of shared co-authors 2
Kuan-Lin Huang
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 28
Juan Xu
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2011
Number of shared co-authors 5
Asha A Nair
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Matan Hofree
Broad Institute of Harvard and MIT
Career Start Year 2010
Number of shared co-authors 9
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 3
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 3
J??ri Reimand
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 36
Xiaotu Ma
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 10
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 19
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 5
Christopher A Maher
Washington University in St Louis
Career Start Year 2006
Number of shared co-authors 19
Chao Cheng
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 11
Kai Wang
Pfizer Inc.
Career Start Year 2004
Number of shared co-authors 2
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 8
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 6
Pedro A F Galante
Hospital Sirio Libanes
Career Start Year 2003
Number of shared co-authors 0
Malachi Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 30
Pavel Sumazin
Baylor College of Medicine
Career Start Year 2003
Number of shared co-authors 27
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 28
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 23
Jorge Estefano Santana de Souza
Instituto Metropole Digital, Universidade Federal do Rio Grande do Norte
Career Start Year 2002
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 39
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 12
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 9
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 33
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 9

Collaborators

Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 36
Timothy C Wang
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Co-authored papers 22
Yuan Yuan
The University of Texas MD Anderson Cancer Center
Co-authored papers 22
Yiling Lu
Co-authored papers 21
Chen Hu
Johns Hopkins University School of Medicine
Co-authored papers 15
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Zhenlin Ju
Co-authored papers 11
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Yanxun Xu
Johns Hopkins University
Co-authored papers 9
Lixia Diao
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Mien-Chie Hung
Co-authored papers 8
Chad J Creighton
Co-authored papers 7
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 6
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
Ji-Yeon Yang
Co-authored papers 5
Garth Powis
PHusis Therapeutics Inc.
Co-authored papers 5
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 5
Wenbin Liu
Co-authored papers 4
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Chen Wang
College of Life Sciences, Sichuan University
Co-authored papers 4
Rachel Karchin
Johns Hopkins University
Co-authored papers 4
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 4
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 4
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 4
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Release 1.2